Profiel
James Mond served as the Chief Medical Officer at Phase III Medical, Inc. before becoming the Executive VP, Chief Scientific & Medical Officer at ADMA Biologics, Inc. where he worked from 2012 to 2021.
Prior to that, he was the Chief Scientific Officer at Biosynexus, Inc. from 1999 to 2011.
He also worked as a Professor at the Uniformed Services University of the Health Sciences.
Dr. Mond holds a doctorate degree from the New York University School of Medicine.
Eerdere bekende functies van James Mond
| Bedrijven | Functie | Einde |
|---|---|---|
| ADMA BIOLOGICS, INC. | Hoofd Techniek/Wetenschap/O&O | 08-06-2021 |
Biosynexus, Inc.
 Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Biosynexus, Inc. develops and markets pharmaceutical products. The company is headquartered in Rockville, MD. | Hoofd Techniek/Wetenschap/O&O | 01-06-2011 |
| Phase III Medical, Inc. | Hoofd Techniek/Wetenschap/O&O | - |
| Uniformed Services University of the Health Sciences | Corporate Officer/Principal | - |
Opleiding van James Mond
| New York University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ADMA BIOLOGICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Biosynexus, Inc.
Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Biosynexus, Inc. develops and markets pharmaceutical products. The company is headquartered in Rockville, MD. | Health Technology |
| Phase III Medical, Inc. | Finance |
